Chemotherapy for Ovarian Germ Cell Tumours

European Journal of Cancer

Volumn 32, Issue 4, 1996, Pages 593-597

  Bower, M ^a   Fife, K ^a   Holden, L ^a   Paradinas, F J ^a   Rustin, G J S ^b   Newlands, E S ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

Chemotherapy; Germ cell tumours; Ovarian

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; FOLINIC ACID; METHOTREXATE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; FOLLOW UP; GERM CELL TUMOR; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CHILD; CHILD, PRESCHOOL; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; FEMALE; GERMINOMA; HUMANS; LEUCOVORIN; METHOTREXATE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; REMISSION INDUCTION; SALVAGE THERAPY; SURVIVAL RATE; VINCRISTINE;

EID: 0029975128     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(95)00598-6     Document Type: Article

References (44)

1. Norris H, Jensen R. Relative frequency of ovarian neoplasms in childhood an adolescence. Cancer 1972, 30, 713-719.
2. Serov S, Scully R, Sobin L. International Histological Classification of Tumors No. 9. Histological Typing of Ovarian Tumors. Geneva, World Health Organisation, 1973.
3. FIGO Cancer Committee. Staging announcement. Gynecol Oncol 1986, 25, 383-385.
4. Newlands ES, Holden L, Bagshawe KD. Tumour markers and POMB/ACE chemotherapy in the management of ovarian germ cell tumours. Int J Biol Markers 1988, 3, 185-192.
5. Williams S, Blessing JA, Liao SY, Ball H, Hanjani P. Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide and bleomycin: a trial of the Gynecological Oncology Group. J Clin Oncol 1994, 12, 701-706.
6. Segelov E, Campbell J, Ng M, et al. Cisplatin-based chemotherapy for ovarian germ cell malignancies: the Australian experience. J Clin Oncol 1994, 12, 378-384.
7. Gershenson DM. Management of early ovarian cancer: germ cell and sex cord-stromal tumors. Gynecol Oncol 1994, 55, S62-S72.
8. Schwartz PE, Chambers SK, Chambers JT, Kohorn E, McIntosh S. Ovarian germ cell malignancies: the Yale University experience. Gynecol Oncol 1992, 45, 26-31.
9. De Palo G, Zambetti M, Pilotti S, et al. Nondysgerminomatous tumors of the ovary treated with cisplatin, vinblastine and bleomycin: long-term results. Gynecol Oncol 1992, 47, 239-246.
10. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 53, 457-481.
11. Peto R, Pike M, Armitage P, et al. Design and analysis of randomised clinical trials requiring prolonged observation of each patient: II analysis and examples. Br J Cancer 1977, 35, 1-39.
12. Gershenson DM. The obsolescence of second-look laparotomy in the management of malignant ovarian germ cell tumors. Gynecol Oncol 1994, 52, 283-285.
13. Williams SD, Blessing JA, Di Saia PJ, Major FJ, Ball HG, Liao SY. Second-look laparotomy in ovarian germ cell tumours: the Gynecological Oncology Group Experience. Gynecol Oncol 1994, 52, 287-291.
14. Germa JR, Izquierdo MD, Segui MA, Climent MA, Ojeda B, Alonso C. Malignant ovarian germ cell tumors: the experience at the Hospital de la Santa Creu i Sant Pau. Gynecol Oncol 1992, 45, 153-159.
15. Read G, Stenning SP, Cullen MH, et al. Medical Research Council prospective study of surveillance for Stage 1 testicular teratoma. J Clin Oncol 1992, 10, 1762-1768.
16. Cangir A, Smith J, Van Eys J. Improved prognosis in children with ovarian cancer following modified VAC (vincristine, dactinomycin and cyclophosphamide) chemotherapy. Cancer 1978, 42, 1234-1238.
17. Schwartz PE. Combination chemotherapy in the management of ovarian germ cell malignancies. Obstet Gynecol 1984, 64, 564-572.
18. Slayton RE, Park RC, Silverberg SG, Shingleton H, Creasman WT, Blessing JA. Vincristine, dactinomycin and cyclophosphamide in the treatment of malignant germ cell tumors of the ovary. A gynecology oncology group study (a final report). Cancer 1985, 56, 243-248.
19. Gershenson DM, Copeland LJ, Kavanagh JJ, et al. Treatment of malignant nondysgerminomatous germ cell tumors of the ovary with vincristine, dactinomycin and cyclophosphamide. Cancer 1985, 56, 2756-2761.
20. Mann JR, Pearson D, Barrett A, Raafat F, Barnes JM, Wallendszus KR. Results of the United Kingdom children's cancer study group's malignant germ cell tumour studies. Cancer 1989, 63, 1657-1667.
21. Carlson R, Sikic BI, Turbow MM, Ballon SC. Combination cisplatin, vinblastine and bleomycin therapy (PVB) for malignant germ cell tumors of the ovary. J Clin Oncol 1983, 1, 645-651.
22. Taylor MH, Depetrillo AD, Turner AR. Vinblastine, bleomycin and cisplatin in malignant germ cell tumours of the ovary. Cancer 1985, 56, 1341-1349.
23. Gershenson DM, Kavanagh JJ, Copeland LJ, et al. Treatment of malignant non dysgerminomatous germ cell tumors of the ovary with vinblastine, bleomycin and cisplatin. Cancer 1986, 57, 1731-1737.
24. Smales E, Peckham MJ. Chemotherapy of germ cell ovarian tumours: first-line treatment with etoposide, bleomycin and cisplatin or carboplatin. Eur J Cancer Clin Oncol 1987, 23, 469-474.
25. Vriesendorp R, Aalders JG, Sleijfer DT, Willemse PHB, Bouma J, Mulder NH. Treatment of malignant germ cell tumors of the ovary with cisplatin, vinblastine and bleomycin (PVB). Cancer Treat Rep 1984, 68, 779-781.
26. Julian CG, Barrett JM, Richardson RL, Greco AF. Bleomycin, vinblastine and cis-platinum in the treatment of advanced endodermal sinus tumor. Obstet Gynecol 1979, 127, 396-401.
27. Wiltshaw E, Stuart-Harris R, Barker GH, Gowing NFC, Raju S. Chemotherapy of endodermal sinus tumour (yolk sac tumour) of the ovary: preliminary communication. J Roy Soc Med 1982, 75, 888-892.
28. Davis TE, Loprinzi CL, Buchler DA. Combination chemotherapy with cisplatin, vinblastine and bleomycin for endodermal sinus tumor of the ovary. Gynecol Oncol 1984, 19, 46-52.
29. Sawada M, Okudaira Y, Matsui Y, Nishiura H, Iwasaki T, Kasamatsu H. Cisplatin, vinblastine and bleomycin therapy of yolk sac (endodermal sinus) tumor of the ovary. Gynecol Oncol 1985, 20, 162-169.
30. Sessa C, Bonazzi C, Landoni F, Pecorelli S, Sartori E, Manigioni C. Cisplatin, vinblastine and bleomycin combination chemotherapy in endodermal sinus tumor of the ovary. Obstet Gynecol 1987, 70, 220-224.
31. Pinkerton CR, Pritchard J, Spitz L. High complete response rate in children with advanced germ cell tumours using cisplatin-containing combination chemotherapy. J Clin Oncol 1986, 4, 194-199.
32. Gershenson DM, Morris M, Cangir A, et al. Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide and cisplatin. J Clin Oncol 1990, 8, 715-720.
33. Newlands ES, Begent RHJ, Rustin GJS, Parker D, Bagshawe KD. Further advances in the management of malignant teratomas of the testis and other sites. Lancet 1983, i, 948-951.
34. Newlands ES, Begent RHJ, Rustin GJS, Bagshawe KD. Potential for cure in metastatic ovarian teratomas and dysgerminomas. Br J Obstet Gynaecol 1982, 89, 555-560.
35. Pedersen-Bjergaard J, Philip P, Larsen SO, Jensen G, Byrsting K. Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia. Blood 1990, 76, 1083-1091.
36. Pui CH, Ribeiro RC, Hancock ML, et al. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med 1991, 325, 1682-1687.
37. Whitlock JA, Greer JP, Lukens JN. Epipodophyllotoxin-related leukemia. Identification of a new subset of secondary leukemia. Cancer 1991, 68, 600-604.
38. Bower M, Parry P, Gibbons B, et al. Human trithorax gene rearrangements in therapy-related acute leukaemia after etoposide treatment. Leukemia 1994, 8, 226-229.
39. Boshoff C, Begent RHJ, Oliver RTD, et al. Secondary tumours following etoposide containing therapy for germ cell cancer. Ann Oncol 1995, 6, 35-40.
40. Pektasides D, Rustin GJS, Newlands ES, Begent RHJ, Bagshawe KD. Fertility after chemotherapy for ovarian germ cell tumours. BrJ Obstet Gynaecol 1987, 94, 477-479.
41. Gershenson DM. Menstrual and reproductive function after treatment with combination chemotherapy for malignant ovarian germ cell tumors. J Clin Oncol 1988, 6, 270-275.
42. Wong LC, Collins RJ, Ngan HY, Ma HK. Etoposide combination chemotherapy in refractory ovarian malignant germ cell tumor. Gynecol Oncol 1990, 39, 123-126.
43. Tonkin KS, Rustin GJS, Wignall B, Paradinas F, Bennett M. Successful treatment of patients in whom germ cell tumour masses enlarged on chemotherapy while their serum tumour markers decreased. Eur JCancer Clin Oncol 1989, 25, 1739-1743.
44. Einhorn LH, Williams SD, Mandelbaum I, Donohue JP. Surgical resection in disseminated testicular cancer following chemotherapeutic cytoreduction. Cancer 1981, 48, 904-908.